BioSpace News Archive

PKU GOLIKE Debuts at SSIEM 2018 Conference: Science Driven Innovation behind the Medical Food for PKU Management of APR Applied Pharma Research

PKU GOLIKE® is the innovative Phenylalanine (Phe)-free medical food formula for Phenylketonuria (PKU), powered by the patented Physiomimic TechnologyTM.

September 13, 2018
·
5 min read
Business

HonorHealth Research Institute Joins the Precision Oncology Alliance

Powered by Caris Life Sciences, the POA advances and broadens patient access to precision medicine through comprehensive tumor profiling

September 13, 2018
·
3 min read
FDA

Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration

Tenapanor is a minimally-systemic small molecule that acts locally in the gastrointestinal (GI) tract to inhibit the sodium transporter NHE3 and reduce sodium uptake from the gut.

September 13, 2018
·
6 min read
Job Trends

Co-Diagnostics Adds Central and South America to its List of International Target Markets

As the Company approaches commercialization of selected molecular diagnostic tests, Latin America joins India and the Caribbean region as important target markets for its products.

September 13, 2018
·
4 min read
IN(3D)USTRY to Gather the Latest 3D-printing Medical Applications

The third edition of In(3D)ustry (http://www.in3dustry.com) will showcase some of the main 3D-printing applications in the medical sector, one of the most innovative sectors that uses this technology.

September 13, 2018
·
2 min read
Deals

DW Healthcare Partners Announces Sale of Reliant Rehabilitation

Reliant is one of the leading providers of contract therapy services to post-acute facilities in the United States.

September 13, 2018
·
1 min read
Policy

Orcas Naturals, Inc. and Unique Encapsulation Technology, LLC Receive UL Inspection and Conformance Certifications

GMPs are guidelines that provide a system of processes, procedures, and documentation to assure a product has the identity, strength, composition, quality, and purity that appear on the product label.

September 13, 2018
·
2 min read
FDA

FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy

The target action date for the FDA decision is May 13, 2019.

September 13, 2018
·
10 min read
FDA

Miransertib (ARQ 092) Granted Fast Track Designation for the Treatment of PIK3CA-Related Overgrowth Spectrum (PROS)

The FDA’s Fast Track program aims to expedite the development and review of drugs which treat serious or life-threatening conditions and have demonstrated the potential to address unmet clinical needs.

September 13, 2018
·
7 min read
Deals

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

This transaction expands AngioDynamics’ growing Oncology business

September 13, 2018
·
5 min read